Daniel P. Silver

10.7k total citations · 1 hit paper
36 papers, 3.9k citations indexed

About

Daniel P. Silver is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Daniel P. Silver has authored 36 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 18 papers in Oncology and 13 papers in Genetics. Recurrent topics in Daniel P. Silver's work include DNA Repair Mechanisms (15 papers), BRCA gene mutations in cancer (11 papers) and PARP inhibition in cancer therapy (8 papers). Daniel P. Silver is often cited by papers focused on DNA Repair Mechanisms (15 papers), BRCA gene mutations in cancer (11 papers) and PARP inhibition in cancer therapy (8 papers). Daniel P. Silver collaborates with scholars based in United States, Denmark and France. Daniel P. Silver's co-authors include David M. Livingston, Eugenia Spanopoulou, David Baltimore, Ralph Scully, Ronald A. DePinho, Zoltán Szállási, Andrea L. Richardson, Nicolai J. Birkbak, Aron C. Eklund and Gail E. Tomlinson and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Daniel P. Silver

35 papers receiving 3.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects

2004 626 citations David A. Tuveson, Alice T. Shaw et al. Cancer Cell profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Daniel P. Silver	2.7k	1.5k	942	656	638	36	3.9k
Lisa A. Moreau	3.3k 1.2×	1.3k 0.9×	629 0.7×	782 1.2×	309 0.5×	46	4.2k
Marieke von Lindern	3.9k 1.4×	633 0.4×	507 0.5×	699 1.1×	618 1.0×	134	5.7k
Ellen Wientjens	2.4k 0.9×	1.8k 1.1×	766 0.8×	420 0.6×	249 0.4×	18	3.3k
Brian Elenbaas	2.8k 1.0×	2.4k 1.6×	511 0.5×	640 1.0×	304 0.5×	26	4.1k
Sally Swift	2.6k 1.0×	1.3k 0.8×	1.1k 1.2×	698 1.1×	196 0.3×	14	3.2k
Leisa Johnson	2.9k 1.1×	1.9k 1.2×	1.2k 1.3×	695 1.1×	362 0.6×	23	4.3k
Eric H. Westin	2.2k 0.8×	819 0.5×	631 0.7×	397 0.6×	759 1.2×	66	3.6k
Andreas Gast	2.1k 0.8×	957 0.6×	607 0.6×	517 0.8×	462 0.7×	28	3.3k
Norihiko Kawamata	2.2k 0.8×	1.4k 0.9×	382 0.4×	588 0.9×	467 0.7×	96	4.0k
Carrie Sougnez	2.1k 0.8×	896 0.6×	585 0.6×	1.1k 1.7×	621 1.0×	27	3.4k

Countries citing papers authored by Daniel P. Silver

Since Specialization

Citations

This map shows the geographic impact of Daniel P. Silver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel P. Silver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel P. Silver more than expected).

Fields of papers citing papers by Daniel P. Silver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel P. Silver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel P. Silver. The network helps show where Daniel P. Silver may publish in the future.

Co-authorship network of co-authors of Daniel P. Silver

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel P. Silver. A scholar is included among the top collaborators of Daniel P. Silver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel P. Silver. Daniel P. Silver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Silver, Daniel P., et al.. (2023). PARP Inhibitors for the Treatment of BRCA1/ 2-Mutated Metastatic Breast Cancer: A Systematic Review and Meta-analysis. Hematology/Oncology and Stem Cell Therapy. 16(3). 186–196. 3 indexed citations

Lavu, Harish, et al.. (2021). Duodenal and Biliary Obstruction due to Extrinsic Compression by Recurrent Lobular Breast Carcinoma: A Case Report. SHILAP Revista de lepidopterología. 15(3). 869–876. 1 indexed citations

Luo, Rui, Weelic Chong, Qiang Wei, et al.. (2021). Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancer. npj Breast Cancer. 7(1). 72–72. 26 indexed citations

Telli, Melinda L., Charles C. Chu, Sunil Badve, et al.. (2019). Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and BRCA1/2 Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis. Clinical Cancer Research. 26(11). 2704–2710. 23 indexed citations

Birkbak, Nicolai J., Y. Li, Shailja Pathania, et al.. (2018). Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers. Annals of Oncology. 29(4). 903–909. 47 indexed citations

Ubellacker, Jessalyn M., Marie‐Therese Haider, Molly J. DeCristo, et al.. (2017). Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells. Breast Cancer Research. 19(1). 23–23. 29 indexed citations

Neupane, Manish, Allison Clark, Serena Landini, et al.. (2015). MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy. Cancer Discovery. 6(1). 45–58. 49 indexed citations

Marquard, Andrea Marion, Aron C. Eklund, Tejal Joshi, et al.. (2015). Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs. Biomarker Research. 3(1). 9–9. 180 indexed citations

Silver, Daniel P., Anu Osinusi, Rachel Silk, et al.. (2013). Effect of HIV on Liver Fibrosis Among HCV-Infected African Americans. Clinical Infectious Diseases. 56(9). 1280–1283. 7 indexed citations

10.

Birkbak, Nicolai J., Zhigang C. Wang, Ji-Young Kim, et al.. (2012). Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents. Cancer Discovery. 2(4). 366–375. 412 indexed citations

11.

Liu, Joyce F. & Daniel P. Silver. (2010). Poly ADP-ribose polymerase inhibitors: science and current clinical development. Current Opinion in Oncology. 22(6). 567–572. 5 indexed citations

12.

Kalaszczyńska, Ilona, Yan Geng, Tadafumi Iino, et al.. (2009). Cyclin A Is Redundant in Fibroblasts but Essential in Hematopoietic and Embryonic Stem Cells. Cell. 138(2). 352–365. 157 indexed citations

13.

Ganesan, Shridar, Andrea L. Richardson, J. Dirk Iglehart, et al.. (2005). Abnormalities of the Inactive X Chromosome Are a Common Feature of BRCA1 Mutant and Sporadic Basal-like Breast Cancer. Cold Spring Harbor Symposia on Quantitative Biology. 70(0). 93–97. 17 indexed citations

14.

Tuveson, David A., Alice T. Shaw, Nicholas A. Willis, et al.. (2004). Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell. 5(4). 375–387. 626 indexed citations breakdown →

15.

Tumey, L. Nathan, David Bom, Bayard R. Huck, et al.. (2004). The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(2). 277–281. 70 indexed citations

16.

Tumey, L. Nathan, Bayard R. Huck, Jianmin Wang, et al.. (2004). The identification and optimization of 2,4-diketobutyric acids as flap endonuclease 1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(19). 4915–4918. 17 indexed citations

17.

Ganesan, Shridar, Daniel P. Silver, Roger A. Greenberg, et al.. (2002). BRCA1 Supports XIST RNA Concentration on the Inactive X Chromosome. Cell. 111(3). 393–405. 226 indexed citations

18.

Silver, Daniel P. & David M. Livingston. (2001). Self-Excising Retroviral Vectors Encoding the Cre Recombinase Overcome Cre-Mediated Cellular Toxicity. Molecular Cell. 8(1). 233–243. 242 indexed citations

19.

Chen, Junjie, Daniel P. Silver, Deepika Walpita, et al.. (1998). Stable Interaction between the Products of the BRCA1 and BRCA2 Tumor Suppressor Genes in Mitotic and Meiotic Cells. Molecular Cell. 2(3). 317–328. 485 indexed citations

20.

Spanopoulou, Eugenia, Patricia Cortés, Charles C.-Y. Shih, et al.. (1995). Localization, interaction, and RNA binding properties of the V(D)J recombination-activating proteins RAG1 and RAG2. Immunity. 3(6). 715–726. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact